Theravance Biopharma Inc (0TB) — Capital Reinvestment Ratio

Latest as of March 2018: 0.06x

Theravance Biopharma Inc (0TB) has a Capital Reinvestment Ratio of 0.06x as of March 2018, meaning it reinvests 0% of its operating cash flow (€49.83 Million) in capital expenditures (€2.77 Million). See net asset quality index of Theravance Biopharma Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

€49.83 Million
EUR

Capital Expenditures

€2.77 Million
EUR

Data as of

Mar 2018
Most recent filing

Annual Capital Reinvestment Ratio for Theravance Biopharma Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Theravance Biopharma Inc from None to None. For live market cap and broader valuation context, see Theravance Biopharma Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow